While waiting for the EVOKE trials, the retrospective propensity matched real world analyses continue to hint at fewer diagnoses of cognitive dysfunction in people on GLP-1 medicines such as semaglutide #T2D Is a 12 month observation period realistic? thelancet.com/journals/eclin…

"We found a beneficial association between #Ozempic and cognitive deficits/nicotine misuse. But much research needs to be done to determine whether this is a causal effect." Riccardo De Giorgi in Peter Cardwell show on Talk. 📺youtube.com/live/2AtSwWFFF… 📰thelancet.com/journals/eclin…

That SARS-CoV-2 infection was systematically and specifically associated with increased risk of "myoneural junction/muscle disease" across all our epidemiological analyses has always puzzled me. Now, this paper by Shuo 烁 might well provide an answer.

NEW PAPER 📢 New study indicates that the new recombinant shingles vaccine could reduce the risk of #dementia compared to a previous vaccine. Led by Maxime Taquet & funded by NIHR Research Oxford Health Biomedical Research Centre the paper is published in Nature Medicine. 👇👇👇 tinyurl.com/39sp6vxb

1/ New Hope Against Dementia: study says singles vaccine also appears to delay onset of dementia with CBS Mornings' Tony Dokoupil Adriana Diaz Nathaniel E Burleson

📢 New Podcast: Riccardo De Giorgi joins Elena Bellafante, Deputy Editor at eClinicalMedicine, to discuss the association between semaglutide and reduced risk of a number of neurological and psychiatric outcomes buzzsprout.com/1845316/155198… Read the Article here: thelancet.com/journals/eclin…

📢Latest BJPsych Journals paper suggests today that taking a specific anticonstipation drug could reduce the risk of #depression . Read more: tinyurl.com/prucalopride

A natural experiment of over 200,000 people who received a shingles vaccine revealed that the recombinant vaccine is associated with lower risk of dementia than the live vaccine, within 6 years of vaccination Maxime Taquet, Oxford Psychiatry, Oxford Health Biomedical Research Centre nature.com/articles/s4159…

New Pioneer Centre, SMARTbiomed, will be advancing applications in medicine and is a research collaboration between University of Oxford, Københavns Uni and Aarhus Universitet, anchored at Aarhus BSS. You can join the research team. See more at smartbiomed.dk.

Is there a name for this (apparent) paradox that can occur when calculating relative risks? 🤔 Both the risks of outcome A and that of outcome B are greater than 1 but the risk of the composite outcome (A or B) is lower than 1.